Nuveen LLC acquired a new stake in Medical Properties Trust, Inc. (NYSE:MPW - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,212,401 shares of the real estate investment trust's stock, valued at approximately $7,311,000. Nuveen LLC owned 0.20% of Medical Properties Trust at the end of the most recent reporting period.
A number of other large investors also recently made changes to their positions in MPW. Charles Schwab Investment Management Inc. increased its holdings in Medical Properties Trust by 13.4% in the first quarter. Charles Schwab Investment Management Inc. now owns 10,020,568 shares of the real estate investment trust's stock valued at $60,424,000 after purchasing an additional 1,182,028 shares during the last quarter. Allianz Asset Management GmbH grew its holdings in Medical Properties Trust by 43.2% during the first quarter. Allianz Asset Management GmbH now owns 7,134,629 shares of the real estate investment trust's stock valued at $43,022,000 after purchasing an additional 2,152,861 shares during the period. Northern Trust Corp grew its holdings in Medical Properties Trust by 60.8% during the fourth quarter. Northern Trust Corp now owns 6,309,149 shares of the real estate investment trust's stock valued at $24,921,000 after purchasing an additional 2,385,081 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Medical Properties Trust by 4.3% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,676,474 shares of the real estate investment trust's stock valued at $14,522,000 after purchasing an additional 150,760 shares during the period. Finally, Principal Financial Group Inc. grew its holdings in Medical Properties Trust by 2.3% during the first quarter. Principal Financial Group Inc. now owns 2,979,094 shares of the real estate investment trust's stock valued at $17,964,000 after purchasing an additional 66,820 shares during the period. Institutional investors and hedge funds own 71.79% of the company's stock.
Analysts Set New Price Targets
A number of research analysts recently issued reports on MPW shares. Wells Fargo & Company decreased their price objective on shares of Medical Properties Trust from $5.00 to $4.50 and set an "underweight" rating for the company in a report on Wednesday. Zacks Research upgraded shares of Medical Properties Trust from a "strong sell" rating to a "hold" rating in a report on Wednesday, August 20th. Wall Street Zen cut shares of Medical Properties Trust from a "hold" rating to a "sell" rating in a report on Saturday, July 5th. Finally, Royal Bank Of Canada reduced their price target on shares of Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating for the company in a report on Monday, June 30th. Two analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $5.58.
Get Our Latest Report on MPW
Medical Properties Trust Stock Up 2.5%
Shares of Medical Properties Trust stock traded up $0.11 on Friday, hitting $4.51. The company had a trading volume of 6,458,687 shares, compared to its average volume of 8,161,871. The stock has a 50-day moving average of $4.25 and a 200-day moving average of $4.88. The company has a debt-to-equity ratio of 2.00, a current ratio of 2.76 and a quick ratio of 2.76. The firm has a market capitalization of $2.71 billion, a P/E ratio of -1.89 and a beta of 1.28. Medical Properties Trust, Inc. has a twelve month low of $3.51 and a twelve month high of $6.55.
Medical Properties Trust (NYSE:MPW - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). Medical Properties Trust had a negative return on equity of 28.80% and a negative net margin of 155.20%.The business had revenue of $240.36 million during the quarter, compared to the consensus estimate of $231.90 million. During the same period in the prior year, the firm earned $0.23 EPS. The business's revenue for the quarter was down 9.8% compared to the same quarter last year. Research analysts predict that Medical Properties Trust, Inc. will post 0.78 earnings per share for the current year.
Medical Properties Trust Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 9th. Stockholders of record on Thursday, September 11th will be given a $0.08 dividend. The ex-dividend date of this dividend is Thursday, September 11th. This represents a $0.32 annualized dividend and a dividend yield of 7.1%. Medical Properties Trust's dividend payout ratio is presently -13.39%.
Medical Properties Trust Profile
(
Free Report)
Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.
Featured Articles

Before you consider Medical Properties Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.
While Medical Properties Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.